“…Synthetic targets included, prodigiosines [198], chartelline alkaloids [199], eupomatilone-3 [200], 9,10-deoxytridachione [201], hamigeran B [202], leprapinic acid and calycin [203], dehydrocoelenterazine analogs [204], gymnocin A (Eq. (11)) [205], murrastifoline A [206], styelsamine C and norsegoline [207], trispheridine [208], dragmacin F [209], ningalin D [210], eupomatilones [211], lucilactaene [47], epoxyquinols A-C and epoxytwinol A [212], mukonine [213], cepharanone [214], ␣ v  3 antagonist [215], alternariol [216], core of roseophilin [21], (−)-callystatin A [217], dibenzo[c,p]chrysene [218], GABA agonist [219,220], diazonamide A [221], dityrosine, trityrosine, pulcherosine [222], lamellarin D [223], integramycin [224], (+)-discodermolide and analogues [225,226], AB-ring system of hexacyclinic acid [227], ␦-trans-tocotrienoloic acid [135], spirofungins [228], kwakhurin [229], toward (+)-and (−)-deplanchein [230], combretastatin analogs [231], diazonamide A [75], cadiolide B [232], pukeleimide A [233], toward apoptolidin [234], polycitone A and B …”